Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Bristol-Myers Squibb generates backup IGF-I receptor inhibitor to BMS-754807 for cancer

Sep. 15, 2010

Ensemble Therapeutics describes Ensemblins

Sep. 15, 2010

GNE-A shows preclinical potential as anticancer agent

Sep. 15, 2010

Clinical data on sevuparin in healthy adults support evaluation in phase II trial in malaria

Sep. 14, 2010

Omecamtiv mecarbil improves left atrial contractility in healthy males

Sep. 14, 2010

New partial 5-HT3 receptor agonist described for treatment of IBS

Sep. 14, 2010

MEDI-578 has analgesic effects in rat model of inflammatory pain

Sep. 14, 2010

New dual mTOR/PI3K-alpha inhibitor PF-04979064 may advance to clinic as anticancer agent

Sep. 14, 2010

Vardenafil improves exercise capacity in phase III trial in subjects with PAH

Sep. 14, 2010

New histamine H4 receptor ligand VUF-11488 to be tested in inflammation models

Sep. 13, 2010

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...